| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |